Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Herbert E. Bates"'
Publikováno v:
Window and Dome Technologies and Materials XIV.
Sapphire’s hardness, strength, and UV-IR transmittance make it an excellent candidate for IR window and transparent armor applications. At Saint-Gobain Crystals, Edge-defined Film-fed Growth (EFG) sapphire crystals are currently being manufactured
Publikováno v:
Window and Dome Technologies and Materials XI.
Demand for larger aperture sapphire IR windows is increasing. To withstand the higher dynamic and pressure forces exerted on them these larger windows require thicker material. Edge Defined Film-fed Growth (EFG) TM Sapphire crystals have traditionall
Autor:
Christopher D. Jones, Jeffrey B. Rioux, Vincent Pluen, John W. Locher, Mattias Mandelartz, Steven A. Zanella, Herbert E. Bates
Publikováno v:
Advances in Ceramic Armor II: Ceramic Engineering and Science Proceedings
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ede93aea4256e902e0463d522432ba00
https://doi.org/10.1002/9780470291368.ch13
https://doi.org/10.1002/9780470291368.ch13
Publikováno v:
Window and Dome Technologies and Materials IX.
Edge Defined Film-fed Growth (EFGTM) Saphikon® sapphire crystals have been grown as large, thick sheet. The sheet is then precision-polished and coated into an infrared or laser transmission compatible window. The sapphire windows are subsequently a
Publikováno v:
Window and Dome Technologies VIII.
Edge Defined film Fed Growth (EFG) Saphikon TM sapphire crystals have been grown and successfully processed into windows measuring 225 x 325 mm with a thickness of 5.6 mm. More than 40 windows have been completed and assembled into customer hardware
Publikováno v:
Journal of the American Pharmaceutical Association (1961). 14:663-666
Autor:
Herbert E. Bates, Gerald W.A. Slywka, Michael R. Ryan, Philip L. Whyatt, Armen P. Melikian, Marvin C. Meyer
Publikováno v:
Journal of the American Pharmaceutical Association. 17(1)
This study correlates cost and bioavailability data on four multiple-source drugs: nitrofurantoin 50 mg, nitrofurantoin 100 mg, propoxyphene 65 mg, and tetracycline 250 mg. There was little correlation between cost and bioavailability within any of t